×
About 14,590 results

ALLMedicine™ Alopecia Center

Research & Reviews  6,773 results

Biallelic splicing variants in the nucleolar 60S assembly factor RBM28 cause the riboso...
https://doi.org/10.1073/pnas.2017777118
Proceedings of the National Academy of Sciences of the Un... Bryant CJ, Lorea CF et. al.

May 4th, 2021 - Alopecia, neurologic defects, and endocrinopathy (ANE) syndrome is a rare ribosomopathy known to be caused by a p.(Leu351Pro) variant in the essential, conserved, nucleolar large ribosomal subunit (60S) assembly factor RBM28. We report the second ...

A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as...
https://doi.org/10.1002/cpdd.935
Clinical Pharmacology in Drug Development; Täubel J, Mazzetti A et. al.

May 4th, 2021 - Cortexolone 17α-propionate, also known as clascoterone, is a potent androgen receptor inhibitor intended for the topical treatment of skin diseases associated with androgenic pathway alterations. In nonclinical studies, cortexolone 17α-propionate ...

Treatment of Pediatric Alopecia Areata: A Systematic Review.
https://doi.org/10.1016/j.jaad.2021.04.077
Journal of the American Academy of Dermatology; Barton VR, Toussi A et. al.

May 3rd, 2021 - Alopecia areata (AA) is an autoimmune, non-scarring hair loss disorder with slightly greater prevalence in children than adults. Various treatment modalities exist; however, their evidence in pediatric AA patients is lacking. We conducted a system...

Clinical features and sex hormone profile in male patients with frontal fibrosing alope...
https://doi.org/10.1016/j.jaad.2021.04.076
Journal of the American Academy of Dermatology; Doche I, Nico MMS et. al.

May 1st, 2021 - Clinical features and sex hormone profile in male patients with frontal fibrosing alopecia: a multicenter retrospective study with 33 patients.|2021|Doche I,Nico MMS,Gerlero P,Rebeis M,Melo DF,|

Chemotherapy as cause of refractory severe headache in a case of small-cell lung cancer.
https://doi.org/10.1136/bcr-2020-240654
BMJ Case Reports; Rai AC, Goyal A et. al.

Apr 29th, 2021 - Small-cell lung cancer (SCLC) is a very fast growing form of cancer and is characterised by early metastasis. As a result, chemotherapy is the mainstay of treatment. Platinum-containing combination regimens are the current treatment of choice for ...

see more →

Guidelines  15 results

Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss...
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.

Jun 4th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Guidelines for management of androgenetic alopecia based on BASP classification--the As...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.

Nov 27th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

British Association of Dermatologists' guidelines for the management of alopecia areata...
https://doi.org/10.1111/j.1365-2133.2012.10955.x
The British Journal of Dermatology; Messenger AG, McKillop J et. al.

Apr 24th, 2012 - British Association of Dermatologists' guidelines for the management of alopecia areata 2012.|2012|Messenger AG,McKillop J,Farrant P,McDonagh AJ,Sladden M,|diagnosis,etiology,therapy,methods,therapeutic use,methods,methods,methods,

Guidelines for the management of androgenetic alopecia (2010).
https://doi.org/10.1111/j.1346-8138.2011.01361.x
The Journal of Dermatology; Tsuboi R, Itami S et. al.

Dec 16th, 2011 - Guidelines for the management of androgenetic alopecia (2010).|2011|Tsuboi R,Itami S,Inui S,Ueki R,Katsuoka K,|therapeutic use,diagnosis,drug therapy,therapeutic use,transplantation,therapeutic use,therapeutic use,

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adole...
https://doi.org/10.1111/j.1365-2133.2010.10011.x
The British Journal of Dermatology; Blume-Peytavi U, Blumeyer A et. al.

Aug 27th, 2010 - Androgenetic alopecia (AGA) is the most common hair loss disorder, affecting both men and women. Due to the frequency and the often significant impairment of life perceived by the affected patients, competent advice, diagnosis and treatment is par...

see more →

Drugs  91 results see all →

Clinicaltrials.gov  7,093 results

Biallelic splicing variants in the nucleolar 60S assembly factor RBM28 cause the riboso...
https://doi.org/10.1073/pnas.2017777118
Proceedings of the National Academy of Sciences of the Un... Bryant CJ, Lorea CF et. al.

May 4th, 2021 - Alopecia, neurologic defects, and endocrinopathy (ANE) syndrome is a rare ribosomopathy known to be caused by a p.(Leu351Pro) variant in the essential, conserved, nucleolar large ribosomal subunit (60S) assembly factor RBM28. We report the second ...

A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as...
https://doi.org/10.1002/cpdd.935
Clinical Pharmacology in Drug Development; Täubel J, Mazzetti A et. al.

May 4th, 2021 - Cortexolone 17α-propionate, also known as clascoterone, is a potent androgen receptor inhibitor intended for the topical treatment of skin diseases associated with androgenic pathway alterations. In nonclinical studies, cortexolone 17α-propionate ...

Treatment of Pediatric Alopecia Areata: A Systematic Review.
https://doi.org/10.1016/j.jaad.2021.04.077
Journal of the American Academy of Dermatology; Barton VR, Toussi A et. al.

May 3rd, 2021 - Alopecia areata (AA) is an autoimmune, non-scarring hair loss disorder with slightly greater prevalence in children than adults. Various treatment modalities exist; however, their evidence in pediatric AA patients is lacking. We conducted a system...

Clinical features and sex hormone profile in male patients with frontal fibrosing alope...
https://doi.org/10.1016/j.jaad.2021.04.076
Journal of the American Academy of Dermatology; Doche I, Nico MMS et. al.

May 1st, 2021 - Clinical features and sex hormone profile in male patients with frontal fibrosing alopecia: a multicenter retrospective study with 33 patients.|2021|Doche I,Nico MMS,Gerlero P,Rebeis M,Melo DF,|

Chemotherapy as cause of refractory severe headache in a case of small-cell lung cancer.
https://doi.org/10.1136/bcr-2020-240654
BMJ Case Reports; Rai AC, Goyal A et. al.

Apr 29th, 2021 - Small-cell lung cancer (SCLC) is a very fast growing form of cancer and is characterised by early metastasis. As a result, chemotherapy is the mainstay of treatment. Platinum-containing combination regimens are the current treatment of choice for ...

see more →

News  597 results

Relapsing Lupus Nephritis and Cutaneous Vasculitis: A Race to Contain B Cells
https://www.medscape.com/viewarticle/949863

Apr 27th, 2021 - This article originally appeared on the Hospital for Special Surgery's website. Case Report A 45-year-old woman with a history of systemic lupus erythematosus (SLE) since 2006 came to the Hospital for Special Surgery in 2014 for continued manageme...

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Oral JAK Inhibitor for Alopecia Areata Advances to Phase 3
https://www.medscape.com/viewarticle/943625

Jan 5th, 2021 - An investigational oral selective Janus kinase 1 and JAK2 inhibitor maintained strong efficacy and tolerability for treatment of alopecia areata through 1 year of use in an ongoing open-label extension study of a trio of 24-week, phase 2 randomize...

New Treatment Options Show Promise for Centrifugal Cicatricial Alopecia
https://www.staging.medscape.com/viewarticle/938538

Oct 4th, 2020 - For patients with central centrifugal cicatricial alopecia (CCCA), several therapies showing benefit in case studies might reasonably be considered for those who have failed standard interventions, according to a review of current strategies for t...

New Treatment Options Show Promise for Centrifugal Cicatricial Alopecia
https://www.medscape.com/viewarticle/938538

Oct 4th, 2020 - For patients with central centrifugal cicatricial alopecia (CCCA), several therapies showing benefit in case studies might reasonably be considered for those who have failed standard interventions, according to a review of current strategies for t...

see more →

Patient Education  21 results see all →